191 related articles for article (PubMed ID: 18246408)
21. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells.
Okamura T; Antoun G; Keir ST; Friedman H; Bigner DD; Ali-Osman F
J Biol Chem; 2015 Dec; 290(52):30866-78. PubMed ID: 26429914
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
[TBL] [Abstract][Full Text] [Related]
24. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
Wang F; Luo Y; Li C; Chen L
Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
[TBL] [Abstract][Full Text] [Related]
25. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
26. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
27. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
28. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
Lo HW; Cao X; Zhu H; Ali-Osman F
Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
30. Reduced connexin43 expression in high-grade human brain glioma cells.
Huang RP; Hossain MZ; Sehgal A; Boynton AL
J Surg Oncol; 1999 Jan; 70(1):21-4. PubMed ID: 9989416
[TBL] [Abstract][Full Text] [Related]
31. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
32. Glioma models.
Dai C; Holland EC
Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
[TBL] [Abstract][Full Text] [Related]
33. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
34. Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.
Burel-Vandenbos F; Turchi L; Benchetrit M; Fontas E; Pedeutour Z; Rigau V; Almairac F; Ambrosetti D; Michiels JF; Virolle T
Neuro Oncol; 2013 Oct; 15(10):1278-88. PubMed ID: 23935154
[TBL] [Abstract][Full Text] [Related]
35. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
36. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
38. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.
Guo G; Gong K; Ali S; Ali N; Shallwani S; Hatanpaa KJ; Pan E; Mickey B; Burma S; Wang DH; Kesari S; Sarkaria JN; Zhao D; Habib AA
Nat Neurosci; 2017 Aug; 20(8):1074-1084. PubMed ID: 28604685
[TBL] [Abstract][Full Text] [Related]
39. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
[TBL] [Abstract][Full Text] [Related]
40. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
Xia S; Li Y; Rosen EM; Laterra J
Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]